5 research outputs found
Tissue-specific ageing of rat tendon-derived progenitor cells
Although ageing predisposes tendons for various pathologies, the effect of ageing on tendon stem/progenitor
cells has received little attention. In this study, we compared tendon progenitor cells from patellar, Achilles and tail
tendons derived from young (8-12 weeks old) and mature (52 weeks old) rats. The mean number of progenitor cells/
mg was reduced with age in all three tendons and this reduction reached statistical significance in both Achilles
and tail tendons. As determined by colony-forming-unit-fibroblasts assays, mean colony number and size were both
statistically unchanged with age in patellar and Achilles tendons. In contrast, both colony number and size were
significantly reduced in cultures derived from mature tail tendons relative to those derived from young tail tendons.
While colonies per mg tissue were reduced with age in all three tendons, this reduction was only statistically significant
for tail tendon. Lipofuscin and ROS content in cell progenitors were unchanged with age in all 3 tendons. Conversely,
carbonyl content was significantly increased and telomerase activity significantly decreased in mature tail tendon
cells relative to young tendon cells. These data suggest that, in the first year of life, rat Achilles and patellar tendons
suffer relatively little oxidative damage. In contrast, tail tendons experience an increase protein oxidation, a decrease
in telomerase activity and a substantial reduction in progenitor cell numbers. That the source and age of tendon
progenitors used influences the quality and density of the progenitor cells isolated from it has important implications
for clinical strategies aimed at tendon repair
Passage and concentration-dependent effects of Indomethacin on tendon derived cells
<p>Abstract</p> <p>Background</p> <p>Non-steroidal anti-inflammatory drugs (NSAID) are commonly used in the treatment of tendinopathies such as tendonitis and tendinosis. Despite this, little is known of their direct actions on tendon-derived cells. As NSAIDs have been shown to delay healing in a number of mesenchymal tissues we have investigated the direct effects of indomethacin on the proliferation of tendon-derived cells.</p> <p>Results and Discussion</p> <p>The results obtained were dependent on both the type of cells used and the method of measurement. When measured using the Alamar blue assay, a common method for the measurement of cell proliferation and viability, no effect of indomethacin was seen regardless of cell source. It is likely that this lack of effect was due to a paucity of mitochondrial enzymes in tendon cells.</p> <p>However, when cell number was assessed using the methylene blue assay, which is a simple nuclear staining technique, an Indomethacin-induced inhibition of proliferation was seen in primary cells but not in secondary subcultures.</p> <p>Conclusion</p> <p>These results suggest that firstly, care must be taken when deciding on methodology used to investigate tendon-derived cells as these cells have a quite different metabolism to other mesenchymal derive cells. Secondly, Indomethacin can inhibit the proliferation of primary tendon derived cells and that secondary subculture selects for a population of cells that is unresponsive to this drug.</p
Investigations into the cell biology of tendon & ligament derived cells
EThOS - Electronic Theses Online ServiceGBUnited Kingdo